Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Men with early hair loss may have higher risks of insulin resistance and metabolic issues.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

A hair test can accurately predict if a person with hair loss will respond to minoxidil treatment.

Retinoic acid affects male and female muscle energy use and function differently.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Early diagnosis and treatment are crucial for complex medical conditions.

Normal BMI is linked to higher rates of androgenetic alopecia.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

The arrector pili muscle plays a key role in hair loss in androgenetic alopecia.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Hair loss may indicate higher risk of heart disease.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

In vitro bioassays are better than traditional methods for measuring androgen activity but aren't ready for routine use yet.

Testosterone use for muscle growth can cause hair loss in males.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Mutations in the androgen receptor gene cause various disorders.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.